Allegretta M, Nicklas J A, Sriram S, Albertini R J
Genetics Laboratory, University of Vermont, Burlington 05401.
Science. 1990 Feb 9;247(4943):718-21. doi: 10.1126/science.1689076.
Gene mutation in vivo in human T lymphocytes appears to occur preferentially in dividing cells. Individuals with multiple sclerosis (MS) are assumed to have one or more populations of diving T cells that are being stimulated by autoantigens. Mutant T cell clones from MS patients were isolated and tested for reactivity to myelin basic protein, an antigen that is thought to participate in the induction of the disease. The hypoxanthine guanine phosphoribosyltransferase (hprt) clonal assay was used to determine mutant frequency values in MS patients with chronic progressive disease. Eleven of 258 thioguanine-resistant (hprt-) T cell clones from five of the six MS patients who were tested proliferated in response to human myelin basic protein without prior in vitro exposure to this antigen. No wild-type clones from these patients, nor any hprt- or wild-type clones from three healthy individuals responded to myelin basic protein. Thus, T cell clones that react with myelin basic protein can be isolated from the peripheral blood of MS patients.
人类T淋巴细胞的基因突变似乎在分裂细胞中更易发生。患有多发性硬化症(MS)的个体被认为有一个或多个被自身抗原刺激的分裂T细胞群体。从MS患者中分离出突变T细胞克隆,并检测其对髓鞘碱性蛋白的反应性,髓鞘碱性蛋白是一种被认为参与疾病诱导的抗原。采用次黄嘌呤鸟嘌呤磷酸核糖转移酶(hprt)克隆分析来确定患有慢性进行性疾病的MS患者的突变频率值。在接受检测的6名MS患者中的5名患者的258个硫鸟嘌呤抗性(hprt-)T细胞克隆中,有11个在未事先体外接触该抗原的情况下,对人髓鞘碱性蛋白产生增殖反应。这些患者中没有野生型克隆,来自三名健康个体的任何hprt-或野生型克隆也不对髓鞘碱性蛋白产生反应。因此,可以从MS患者的外周血中分离出与髓鞘碱性蛋白反应的T细胞克隆。